enbucrilate has been researched along with vasoactive intestinal peptide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, XF; Lin, L; Liu, Y; Liu, ZH; Wang, WF; Xu, ZR; Zhu, X | 1 |
1 other study(ies) available for enbucrilate and vasoactive intestinal peptide
| Article | Year |
|---|---|
Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.
Topics: Apoptosis; Cell Line, Tumor; Enbucrilate; Humans; Nanoparticles; Neurons; Neuroprotective Agents; Oxidopamine; Vasoactive Intestinal Peptide | 2015 |